Tag Archives: Pre-money valuation

Biotech Valuation Inflation: Public Exuberance Meets Private Rounds?
September 21, 2015

With the NASDAQ sector indices still up 17% for the year, and IPOs continuing at a robust pace, the biotech investing climate continues to be an exciting one. Amidst these rising stock prices, or at least perceptions, I frequently get

Leave a comment